효소면역측정법(ELISA) : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)
Enzyme-Linked Immunosorbent Assay (ELISA) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
상품코드:1872183
리서치사:QYResearch
발행일:2025년 10월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 효소면역측정법(ELISA) 시장 규모는 2024년에 17억 9,100만 달러로 추정되며, 2025-2031년의 예측 기간에 CAGR 4.2%로 추이하며, 2031년까지 23억 7,300만 달러로 확대할 것으로 예측되고 있습니다.
이 보고서는 효소면역측정법(ELISA)의 국경 간 산업적 발자취, 자본 배분 패턴, 지역 경제의 상호의존성, 공급망 재구축, 최근 관세 조정 및 국제적인 전략적 대응 조치에 대한 종합적인 평가를 제공합니다.
ELISA 키트(효소면역측정법)는 효소면역측정 기술 중 가장 널리 사용되는 기술입니다. 효소면역측정법(ELISA)은 효소면역측정법(EIA)이라고도 하며, 주로 면역학에서 시료내 항체 또는 항원의 존재를 검출하기 위해 사용되는 생화학적 방법입니다. ELISA 키트에서는 포획 항체를 고체상대체에 결합시킵니다. 알려진 항원 또는 미지의 항원을 포함하는 샘플은 고상에 대한 부착을 최소화하는 매트릭스 또는 완충액에 첨가됩니다. 그 후, 검출을 위해 효소 표지 항체를 첨가합니다. 효소면역측정법(ELISA)은 항체를 이용하여 액체 시료내 표적 분석물의 존재를 검출 및 정량하는 플레이트 기반 분석 기술입니다.
효소면역측정법(ELISA) 시장은 진단, 조사, 품질관리 등 다양한 분야에 적용되면서 꾸준히 성장하고 있습니다. ELISA는 생물학적 시료내 단백질, 호르몬, 항체, 병원체를 검출 및 정량하기 위한 고감도, 고특이성의 면역측정법입니다. 감염, 자가면역질환, 암 바이오마커의 임상 진단과 신약개발 및 의약품 연구에 중요한 역할을 하고 있습니다. 여러 샘플을 동시에 처리할 수 있는 능력과 비용 효율성 및 자동화와의 호환성으로 인해 ELISA는 전 세계 실험실에서 선호되는 선택이 되고 있습니다.
시장 성장은 질병의 조기 발견에 대한 수요 증가, 면역 진단 기술의 발전, 생명과학 연구에 대한 투자 증가로 인해 더욱 가속화되고 있습니다. 이 기술은 현장 검사 및 하이스루풋 스크리닝에도 적용되어 의료 및 생명공학 분야 전반에 걸쳐 유용성을 높이고 있습니다. 그러나 교차 반응성 위험, 숙련된 인력의 필요성, PCR 및 차세대 염기서열 분석과 같은 첨단 분자진단 툴와의 경쟁 등의 문제로 인해 특정 영역에서의 보급을 제한할 수 있습니다. 이러한 장벽에도 불구하고 ELISA는 분석 형식과 검출 시스템의 지속적인 혁신을 통해 임상 현장과 연구 환경 모두에서 기반 기술로서의 지위를 유지하고 있습니다.
이 보고서는 효소면역측정법(ELISA) 세계 시장에 대해 총판매량, 판매 매출, 가격, 주요 기업의 시장 점유율 및 순위를 중심으로 지역별, 국가별, 유형별, 용도별 분석을 종합적으로 제시하는 것을 목적으로 합니다.
효소면역측정법(ELISA) 시장 규모, 추정 및 예측은 판매량(천 단위) 및 매출액(백만 달러)으로 제시되며, 2024년을 기준 연도, 2020-2031년의 과거 데이터와 예측 데이터를 포함하는 2024-2031년의 기간으로 추정 및 예측합니다. 정량적 분석과 정성적 분석을 통해 독자들이 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, 효소면역측정법(ELISA)에 대한 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 도와드립니다.
시장 세분화
기업별
Thermo Fisher Scientific
Enzo Life Sciences
BioLegend
Merck
Bio-Techne
BD Biosciences
Bio-Rad Laboratorie
Aviva Systems Biology
Repligen
Lifespan Biosciences
PerkinElmer
BioVision
Innovative Research
Biomatik
Shanghai Kehua Bio-Engineering
Biomerieux
유형별 부문
간접 ELISA
샌드위치 ELISA
경쟁 ELISA
기타
용도별 부문
실험실
검사 기관
병원
기타
지역별
북미
미국
캐나다
아시아태평양
중국
일본
한국
동남아시아
인도
호주
기타 아시아태평양
유럽
독일
프랑스
영국
이탈리아
네덜란드
북유럽 국가
기타 유럽
라틴아메리카
멕시코
브라질
기타 라틴아메리카
중동 및 아프리카
튀르키예
사우디아라비아
아랍에미리트
기타 중동 및 아프리카
KSA
영문 목차
영문목차
The global market for Enzyme-Linked Immunosorbent Assay (ELISA) was estimated to be worth US$ 1791 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Enzyme-Linked Immunosorbent Assay (ELISA) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
ELISA Kit (enzyme-linked immunosorbent assay) is the most widely used technology in enzyme immunoassay technology. Enzyme-linked immunosorbent assay (ELISA), also known as an enzyme immunoassay (EIA), is a biochemical technique used mainly in immunology to detect the presence of an antibody or an antigen in a sample. ELISA kit involve attachment of a capture antibody to a solid phase support. Samples containing known or unknown antigen are then added in a matrix or buffer that will minimize attachment to the solid phase. An enzyme-labeled antibody is then added for detection. Enzyme-linked immunosorbent assay (ELISA) is an analytical, plate-based technique to detect and quantify the presence of an target analyte in a liquid sample using antibodies.
The Enzyme-Linked Immunosorbent Assay (ELISA) market is growing steadily, driven by its wide application in diagnostics, research, and quality control. ELISA is a highly sensitive and specific immunoassay used to detect and quantify proteins, hormones, antibodies, and pathogens in biological samples. It plays a critical role in clinical diagnostics for infectious diseases, autoimmune disorders, and cancer biomarkers, as well as in drug development and pharmaceutical research. Its ability to process multiple samples simultaneously, coupled with cost-effectiveness and compatibility with automation, makes ELISA a preferred choice for laboratories worldwide.
Market growth is further fueled by the increasing demand for early disease detection, advancements in immunodiagnostic technologies, and rising investment in life sciences research. The technique is also being adapted for use in point-of-care testing and high-throughput screening, improving its utility across healthcare and biotechnology sectors. However, challenges such as the risk of cross-reactivity, the need for skilled personnel, and competition from advanced molecular diagnostic tools like PCR and next-generation sequencing can limit adoption in certain areas. Despite these hurdles, ongoing innovations in assay formats and detection systems ensure that ELISA remains a cornerstone technology in both clinical and research settings.
This report aims to provide a comprehensive presentation of the global market for Enzyme-Linked Immunosorbent Assay (ELISA), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Enzyme-Linked Immunosorbent Assay (ELISA) by region & country, by Type, and by Application.
The Enzyme-Linked Immunosorbent Assay (ELISA) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzyme-Linked Immunosorbent Assay (ELISA).
Market Segmentation
By Company
Thermo Fisher Scientific
Enzo Life Sciences
BioLegend
Merck
Bio-Techne
BD Biosciences
Bio-Rad Laboratorie
Aviva Systems Biology
Repligen
Lifespan Biosciences
PerkinElmer
BioVision
Innovative Research
Biomatik
Shanghai Kehua Bio-Engineering
Biomerieux
Segment by Type
Indirect ELISA
Sandwich ELISA
Competitive ELISA
Others
Segment by Application
Laboratory
Testing Institutions
Hospital
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Enzyme-Linked Immunosorbent Assay (ELISA) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Enzyme-Linked Immunosorbent Assay (ELISA) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Enzyme-Linked Immunosorbent Assay (ELISA) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
2.9.2 Global 5 and 10 Largest Manufacturers by Enzyme-Linked Immunosorbent Assay (ELISA) Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Indirect ELISA
3.1.2 Sandwich ELISA
3.1.3 Competitive ELISA
3.1.4 Others
3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type
3.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, by Type (2020-2031)
3.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, by Type (%) (2020-2031)
3.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Type
3.3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume, by Type (2020-2031)
3.3.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume, by Type (%) (2020-2031)
3.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Laboratory
4.1.2 Testing Institutions
4.1.3 Hospital
4.1.4 Others
4.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application
4.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, by Application (2020-2031)
4.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, by Application (%) (2020-2031)
4.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Application
4.3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume, by Application (2020-2031)
4.3.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume, by Application (%) (2020-2031)
4.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region
5.1.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (2020-2025)
5.1.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (2026-2031)
5.1.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (%), (2020-2031)
5.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region
5.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region (2020-2025)
5.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region (2026-2031)
5.2.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region (%), (2020-2031)
5.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
5.4.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
5.5.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
5.6.2 Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
5.7.2 South America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
5.8.2 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value and Sales Volume
